Recent data indicate that uTIMP‐2, along with other biomarkers such as NGAL, can help in the early diagnosis of AKI by detecting kidney stress before clinically relevant functional decline, allowing for better differentiation between AKI and other diseases [18]. Here, LCN2 is linked to acute kidney injury.